Abstract:Background: The mixed lineage kinase domain-like protein has recently been identified as a key downstream component of tumor necrosis factor–induced necroptosis, which is an important pathway of cancer cell death. The goal of the current study is to explore the expression of mixed lineage kinase domain-like protein in colon cancer tissues and evaluate the prognostic value in patients with colon cancer. Methods: We collected normal and cancer colon tissues from 135 patients diagnosed with colon cancer after radical operation during July 2007 to April 2009 at The Affiliated Hospital of Qingdao University. Immunohistochemistry analysis was scored using an established scoring system. Kaplan-Meier survival curves were generated for recurrence-free survival and overall survival for all patients and 2 subsets of patients. The relationship between mixed lineage kinase domain-like protein expression and prognosis parameter (recurrence-free survival, overall survival) was analyzed by univariate and multivariate Cox regression analyses. Results: The median age of all patients was 67 years and 56.3% were male. Low expression of mixed lineage kinase domain-like protein was associated with decreased overall survival (78.6 vs 81.2 months; P = .011) in all patients. In the subset of 79 patients who received adjuvant chemotherapy, low expression of mixed lineage kinase domain-like protein was associated with decreased recurrence-free survival (60.4 vs 72.8 months; P = .032) and decreased overall survival (66.3 vs 72.9 months; P = .005). Low expression of mixed lineage kinase domain-like protein was associated with decreased overall survival (74.9 vs 79.8 months; P = .006) and recurrence-free survival (69.6 vs 78.8 months; P = .005) among patients with Tumor Node Metastasis (TNM) stage II colon cancer. Conclusions: Low expression of mixed lineage kinase domain-like protein was associated with decreased overall survival in all patient-group with resected colon cancer. It is associated with decreased recurrence-free survival and overall survival in the subset of patients who receive adjuvant chemotherapy and patients who were TNM stage II. Mixed lineage kinase domain-like protein may provide important prognostic information in patients with colon cancer.

Mixed Lineage Kinase Domain-Like Protein is a Prognostic Biomarker for Cervical Squamous Cell Cancer.

Prognostic Value of Mixed Lineage Kinase Domain-Like Protein Expression in the Survival of Patients with Gastric Caner

Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis

MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer

MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC)

Association of Mixed Lineage Kinase Domain-Like Protein Expression With Prognosis in Patients With Colon Cancer

Identification of CRKL as an oncogenic biomarker for prognosis and immunotherapy in melanoma, and its potential molecular mechanism

Higher Mixed lineage Kinase Domain-like protein (MLKL) is associated with worst overall survival in adult-type diffuse glioma patients

Overexpression of KLHL22 Correlates with Poor Prognosis in Patients with Triple-Negative Breast Cancer.

Kallikrein-related Peptidase 5 Induces Mirna-Mediated Anti-Oncogenic Pathways in Breast Cancer.

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

Clinical and Biological Significance of Nemo-Like Kinase Expression in Glioma.

MLKL in cancer: more than a necroptosis regulator

MKL1 overexpression predicts poor prognosis in patients with papillary thyroid cancer and promotes nodal metastasis

KLHL5 is a Prognostic-Related Biomarker and Correlated with Immune Infiltrates in Gastric Cancer

Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancer

Overexpression of Mitogen-Activated Protein Kinase Kinase 4 and Nuclear Factor-Kappab in Laryngeal Squamous Cell Carcinoma: a Potential Indicator for Poor Prognosis.

Myeloid Cell Leukemia-1 Inversely Correlates with Glycogen Synthase Kinase-3 Beta Activity and Associates with Poor Prognosis in Human Breast Cancer

[Expression of KLK6 Protein and Mrna in Primary Breast Cancer and Its Clinical Significance].

NLRC5 promotes tumorigenesis by regulating the PI3K/AKT signaling pathway in cervical cancer

A necroptotic-independent function of MLKL in regulating endothelial cell adhesion molecule expression